Dr Watson is an employee of Merck & Co., Inc. which manufactures HMG-CoA Reductase Inhibitors.
Liver function testing in patients on HMG-CoA reductase inhibitors†
Article first published online: 26 MAR 2003
Copyright © 2003 John Wiley & Sons, Ltd.
Pharmacoepidemiology and Drug Safety
Volume 12, Issue 4, pages 307–313, June 2003
How to Cite
Andrade, S. E., Donahue, J. G., Chan, K. A., Watson, D. J. and Platt, R. (2003), Liver function testing in patients on HMG-CoA reductase inhibitors. Pharmacoepidem. Drug Safe., 12: 307–313. doi: 10.1002/pds.832
This study was presented in part at the 16th International Conference on Pharmacoepidemiology, Barcelona, Spain, 21 August 2000.
- Issue published online: 14 MAY 2003
- Article first published online: 26 MAR 2003
- Manuscript Accepted: 10 SEP 2002
- Manuscript Received: 29 MAY 2002
- Merck & Co., Inc.